Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies.It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials. The company was incorporated in 1990 and is headquartered in Foster City, California.
